Using mRNA-based vaccinations in conjunction with conventional lipid-lowering medications like PCSK9 inhibitors and statins offers an intriguing way to improve the effectiveness of atherosclerosis therapy. This evidence concerns the gene PCSK9 and atherosclerosis.